Henry Schein to Present at Upcoming Investor Conferences

Rhea-AI Summary

Henry Schein, listed on Nasdaq as HSIC, announced its participation in three upcoming investor conferences. These include the Piper Sandler’s 34th Annual Healthcare Conference on November 30, 2022, at 9:00 a.m. ET, the Evercore ISI HealthCONx Virtual Conference on December 1, 2022, at 11:20 a.m. ET, and the Nasdaq 47th Investor Conference in London on December 6, 2022, at 10:30 a.m. GMT / 5:30 a.m. ET. Presentations will be available via live webcast and replays on the company’s website.

MELVILLE, N.Y.--(BUSINESS WIRE)-- Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences:

• Piper Sandler’s 34^th Annual Healthcare Conference at the Lotte New York Palace on November 30, 2022, at 9:00 a.m. Eastern time.
• Evercore ISI HealthCONx Virtual Conference on December 1, 2022, at 11:20 a.m. Eastern time.
• Nasdaq 47^th Investor Conference at the May Fair Hotel, London, on December 6, 2022, at 10:30 a.m. GMT / 5:30 a.m. Eastern time.

Henry Schein’s presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. Replays will be available on the Henry Schein website following the presentations.

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 22,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 32 countries and territories. The Company's sales reached $12.4 billion in 2021, and have grown at a compound annual rate of approximately 12.5 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, and @HenrySchein on Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221108005871/en/

Investors

Ronald N. South

Senior Vice President and Chief Financial Officer

ronald.south@henryschein.com

(631) 845-2802

Graham Stanley

Vice President, Investor Relations and Strategic Financial Project Officer

graham.stanley@henryschein.com

(631) 843-5963

Media

Ann Marie Gothard

Vice President, Global Corporate Media Relations

annmarie.gothard@henryschein.com

(631) 390-8169

Source: Henry Schein, Inc.

FAQ

What conferences will Henry Schein, symbol HSIC, participate in November 2022?

Henry Schein will present at Piper Sandler’s 34th Annual Healthcare Conference on November 30, 2022, and at the Evercore ISI HealthCONx Virtual Conference on December 1, 2022.

What is the date and time for Henry Schein's Nasdaq Investor Conference?

The Nasdaq 47th Investor Conference will be held on December 6, 2022, at 10:30 a.m. GMT / 5:30 a.m. Eastern time.

Where can investors watch Henry Schein's conference presentations?

Investors can watch live webcasts of Henry Schein's presentations at www.henryschein.com/IRwebcasts.

How has Henry Schein performed financially recently?

In 2021, Henry Schein reported sales of $12.4 billion, showing a compound annual growth rate of approximately 12.5% since going public in 1995.